Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. On January 30, 2026, vTv Therapeutics LLC (“vTv LLC” or the "Company"), a subsidiary of vTv Therapeutics Inc., enter